...
首页> 外文期刊>Regulatory Toxicology and Pharmacology: RTP >Toxicological evaluation of ammonium 4,8-dioxa-3H-perfluorononanoate, a new emulsifier to replace ammonium perfluorooctanoate in fluoropolymer manufacturing.
【24h】

Toxicological evaluation of ammonium 4,8-dioxa-3H-perfluorononanoate, a new emulsifier to replace ammonium perfluorooctanoate in fluoropolymer manufacturing.

机译:4,8-二氧杂-3H-全氟壬酸铵的毒理学评估,一种新型的乳化剂,可替代含氟聚合物生产中的全氟辛酸铵。

获取原文
获取原文并翻译 | 示例
           

摘要

Ammonium 4,8-dioxa-3H-perfluorononanoate (ADONA) was developed to replace ammonium perfluorooctanoate (APFO) as an emulsifier in the manufacture of fluoropolymers. The toxicity of ADONA was evaluated in acute and repeat-dose studies of up to 90-days duration, and in eye and skin irritation, dermal sensitization, genotoxicity, and developmental toxicity studies. ADONA was also evaluated as a peroxisome proliferator-activated receptor alpha (PPARalpha) agonist in rats. ADONA was moderately toxic orally and practically non-toxic dermally in acute studies in rats. It was a mild skin irritant and a moderate to severe eye irritant in rabbits. It was a weak dermal sensitizer in local lymph node assays in mice. ADONA was not genotoxic based on the weight of evidence from five assays. It was not developmentally toxic in rats except at maternally toxic doses. ADONA was a possible PPARalpha agonist in male rats. The liver was the primary target organ in male rats and the kidney was the primary target organ in female rats. NOAELs in 28- and 90-day oral studies in rats were 10mg/kg/day for males and 100mg/kg/day for females. These findings demonstrate that the toxicity profile for ADONA is acceptable for its intended use and is superior to that of APFO.
机译:开发了4,8-二氧杂-3H-全氟壬酸铵(ADONA)来代替全氟辛酸铵(APFO)作为制造含氟聚合物的乳化剂。在长达90天的急性和重复剂量研究中,以及在对眼睛和皮肤的刺激,皮肤致敏性,遗传毒性和发育毒性研究中,评估了ADONA的毒性。 ADONA还被评估为大鼠中的过氧化物酶体增殖物激活受体α(PPARalpha)激动剂。在大鼠的急性研究中,口服ADONA对皮肤有中等毒性,而对皮肤几乎无毒。它在兔子中对皮肤有轻度刺激性,对眼睛有中度至重度刺激性。在小鼠局部淋巴结试验中,它是一种弱的皮肤致敏剂。基于五种测定的证据权重,ADONA没有遗传毒性。除了对母体有毒性剂量外,它对大鼠没有发育毒性。 ADONA是雄性大鼠中可能的PPARα激动剂。肝脏是雄性大鼠的主要靶器官,而肾脏是雌性大鼠的主要靶器官。在28天和90天的大鼠口服研究中,NOAEL的雄性为10mg / kg /天,雌性为100mg / kg /天。这些发现表明,对于ADONA的毒性特性,对于其预期用途是可以接受的,并且优于APFO。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号